Experiences with
Behavioural therapy16,912 public posts
Want to take advantage of all our features? Just log in!
or
Update on trametinib (Mekinist) for low grade serous ovarian cancer
Good morning everyone
We are delighted that NHS England has recommended that the MEK-inhibitor trametinib (Mekinist) should be routinely available as an off-label treatment option for adults with recurrent or progressive low grade serous ovarian cancer (LGSOC). This is for people who have received